Q2 STOCKS TO BUY

Chemours Stock Dips Amid Slowing Demand

Quarter-to-date, CC is still up more than 25%

Digital Content Manager
Nov 29, 2022 at 10:34 AM
facebook X logo linkedin


The shares of Chemours Co (NYSE:CC) are down 1.4% to trade at $30.96 this morning, after the company noted slowing titanium dioxide demand in Europe and Asia has its full-year earnings results falling behind its previously issued outlook.

The security is slipping below its 20-day moving average, after conquering this trendline in mid-October and spending most of November well above it. What's more, the equity's last rally lost steam before reaching the $35 level, though quarter-to-date CC is still up 25.2%.

The brokerage bunch is skeptical of CC, with eight of 10 firms in coverage carrying a tepid "hold" rating, while the 12-month consensus target price of $33.50 is a 7.6% premium to current levels.

What's more, the equity's Schaeffer's put/call open interest ratio (SOIR) of 1.28 ranks in the relatively low 28th percentile of annual readings, indicating short-term options traders have been more call-biased than usual. 

CC's Schaeffer's Volatility Scorecard (SVS) sits at 98 out of 100, meaning the security has exceeded options traders' volatility expectations over the past year.

 

“Buy This Stock Now!” - Expert Who Called 11x On TSLA

He called a rare 11x on Tesla…

But now, thanks to Elon & Trump’s new alliance…

He says there’s a new opportunity that could be 1,000x BIGGER than Tesla – and it could completely revolutionize a $23 Trillion market.

It’s trading for less than $5 per share right now…

But it won’t be under the radar for long.

Discover The 1,000x Bigger Elon Opportunity Here